Altria Group Inc
NYSE: MO
$52.38
-$0.22 (-0.4%)
Closing Price on December 27, 2024
MO Articles
Counting out a tobacco company has never proved to be a good bet over the long term. Will this time be different?
Published:
Cigarette smoking is falling out of favor but Altria could still appeal to investors as it looks to tobacco alternatives.
Published:
Altria wants to diversify into e-cigarettes and legal pot, but faces regulatory action, patent litigation and coronavirus-related setbacks.
Published:
U.K. tobacco giant Imperial Brands has slashed its dividend. Will American tobacco companies follow suit?
Published:
Last Updated:
When the economy began to face an instant recession from the coronavirus, even before the name COVID-19 became labeled a pandemic, the phenomena of buying defensive stocks was thrown out the window....
Published:
Altria's share price is falling. Its investments have been busts, and hedge funds and shareholders are getting cranky. Even the dividend hasn't made investors happy.
Published:
Altria’s investments in Juul and Cronos Group weigh on investor sentiment even though core tobacco business looks strong.
Published:
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Published:
Altria Group Inc. investors will want to note the latest setbacks for e-cigarette manufacturer Juul Labs, which include regulatory troubles, adverse publicity around the health effects of vaping, and...
Published:
With investments in booze, pot, tobacco and e-cigarettes, Altria has the sin category just about covered. However, the COVID-19 outbreak may indicate that the cost of sin has limits.
Published:
A combination of financial factors creates an interesting value proposition for investors as Altria reports later this week. Also, we will get a chance to see if anything happens with the dividend.
Published:
Since the beginning of the year, tobacco giant Altria saw its stock price dive. Investors may wonder if the dividend is safe.
Published:
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Published:
The U.S. Federal Trade Commission has filed a lawsuit alleging that Altria Group's $12.8 billion investment in e-cigarette maker Juul violated various U.S. antitrust laws.
Published:
Investors are scrambling to find yield. Could Altria have just the dividend yield they are looking for? Cigarettes have been considered recession-proof, but this time things may be somewhat different.
Published: